Substrate transport and cocaine binding of human dopamine transporter is reduced by substitution of carboxyl tail with that of bovine dopamine transporter
- 1 July 1997
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 8 (11) , 2591-2594
- https://doi.org/10.1097/00001756-199707280-00034
Abstract
A chimeric dopamine transporter (DAT) cDNA encoding mutant human DAT (hDAT) protein in which the intracellular carboxyl-terminal tail is replaced by that of the bovine dopamine transporter (bDAT) was constructed. The chimeric hDAT cDNA was expressed in COS-7 cells, and [3H]dopamine and [3H]MPP+ uptake and [3H]CFT binding capacities were assessed. Substrate transport and ligand binding of bDAT were reduced by 32–43% as a result of substitution of the carboxyl tail in hDAT, suggesting that the functional characteristics of bDAT arise from differences in the carboxyl tail between human and bovine DAT. Thus, it appears that the sequences encoded within the carboxyl terminal of DAT would be one of the important determinants for its functions.Keywords
This publication has 7 references indexed in Scilit:
- Identification of domains of a cloned rat brain GABA transporter which are not required for its functional expressionFEBS Letters, 1993
- Transporter explosion: update on uptakeTrends in Pharmacological Sciences, 1992
- Neurotransmitter transporters (plus): a promising new gene familyTrends in Neurosciences, 1992
- Parkinsonism‐inducing neurotoxin MPP+: Uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNAAnnals of Neurology, 1992
- Dopamine uptake: A review of progress in the last decadeProgress in Neurobiology, 1990
- MPTPNeurology, 1986
- Role of Transmitter Uptake Mechanisms in Synaptic NeurotransmissionBritish Journal of Pharmacology, 1971